(Q43831214)

27 November 2017

Reactivation of precore mutant hepatitis B virus in chemotherapy-treated patients (English)

1 reference

27 November 2017

1 reference

1 reference

Dai MS

1

1 reference

27 November 2017

Lu JJ

2

1 reference

27 November 2017

Chen YC

3

1 reference

27 November 2017

Perng CL

4

1 reference

27 November 2017

Chao TY

5

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

27 November 2017

1 reference

27 November 2017

92

1 reference

27 November 2017

11

1 reference

27 November 2017

2927-2932

1 reference

Prevalence of hepatitis B virus marker positivity and evolution of hepatitis B virus profile, during chemotherapy, in patients with solid tumours

27 November 2017

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2927%3A%3AAID-CNCR10109%3E3.0.CO%3B2-W

Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2927%3A%3AAID-CNCR10109%3E3.0.CO%3B2-W

Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2927%3A%3AAID-CNCR10109%3E3.0.CO%3B2-W

Biologic properties of hepatitis B viral genomes with mutations in the precore promoter and precore open reading frame

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2927%3A%3AAID-CNCR10109%3E3.0.CO%3B2-W

Acute exacerbation of hepatitis due to reactivation of hepatitis B virus with mutations in the core region after chemotherapy for malignant lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2927%3A%3AAID-CNCR10109%3E3.0.CO%3B2-W

Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2927%3A%3AAID-CNCR10109%3E3.0.CO%3B2-W

Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2927%3A%3AAID-CNCR10109%3E3.0.CO%3B2-W

Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2927%3A%3AAID-CNCR10109%3E3.0.CO%3B2-W

The role of pre-core hepatitis B virus mutants on the long-term outcome of chronic hepatitis B virus hepatitis. A longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2927%3A%3AAID-CNCR10109%3E3.0.CO%3B2-W

Sequence variations of precore/core and precore promoter regions of hepatitis B virus in patients with or without viral reactivation during cytotoxic chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2927%3A%3AAID-CNCR10109%3E3.0.CO%3B2-W

Lamivudine treatment for chronic replicative hepatitis B virus infection after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2927%3A%3AAID-CNCR10109%3E3.0.CO%3B2-W

Prevention of hepatitis B flare-up during chemotherapy using lamivudine: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2927%3A%3AAID-CNCR10109%3E3.0.CO%3B2-W

Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2927%3A%3AAID-CNCR10109%3E3.0.CO%3B2-W

Long-term therapy of chronic hepatitis B with lamivudine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2927%3A%3AAID-CNCR10109%3E3.0.CO%3B2-W

Incidence of hepatitis B virus infections in preschool children in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2927%3A%3AAID-CNCR10109%3E3.0.CO%3B2-W

Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2927%3A%3AAID-CNCR10109%3E3.0.CO%3B2-W

10.1002/1097-0142(20011201)92:11<2927::AID-CNCR10109>3.0.CO;2-W

21 January 2018

Identifiers

DOI

1 reference

release_46jlf33avjerfaph3iddj45ngu

27 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/46jlf33avjerfaph3iddj45ngu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference